Moleculin Biotech posts August 2025 investor presentation; content not disclosed in filing

Moleculin Biotech, Inc.

Filed 8-K on August 18, 2025, attaching investor presentation as Exhibit 99.1.
Presentation dated August 2025; no specific financial or operational data extracted from the filing.
No changes to previously disclosed guidance or material events evident from the filing alone.

item 7.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.